226 related articles for article (PubMed ID: 26855828)
1. Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Wetter NC; Hubbard EA; Motl RW; Sutton BP
Brain Behav; 2016 Mar; 6(3):e00440. PubMed ID: 26855828
[TBL] [Abstract][Full Text] [Related]
2. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.
Jakimovski D; Weinstock-Guttman B; Hagemeier J; Vaughn CB; Kavak KS; Gandhi S; Bennett SE; Fuchs TA; Bergsland N; Dwyer MG; Benedict RHB; Zivadinov R
J Neurol Sci; 2018 Oct; 393():128-134. PubMed ID: 30165291
[TBL] [Abstract][Full Text] [Related]
3. Whole-brain atrophy assessed by proportional- versus registration-based pipelines from 3T MRI in multiple sclerosis.
Hemond CC; Chu R; Tummala S; Tauhid S; Healy BC; Bakshi R
Brain Behav; 2018 Aug; 8(8):e01068. PubMed ID: 30019857
[TBL] [Abstract][Full Text] [Related]
4. Number of MRI T1-hypointensity corrected by T2/FLAIR lesion volume indicates clinical severity in patients with multiple sclerosis.
Akaishi T; Takahashi T; Fujihara K; Misu T; Mugikura S; Abe M; Ishii T; Aoki M; Nakashima I
PLoS One; 2020; 15(4):e0231225. PubMed ID: 32243459
[TBL] [Abstract][Full Text] [Related]
5. MRI T2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis.
Tjoa CW; Benedict RH; Weinstock-Guttman B; Fabiano AJ; Bakshi R
J Neurol Sci; 2005 Jul; 234(1-2):17-24. PubMed ID: 15993137
[TBL] [Abstract][Full Text] [Related]
6. Whole brain and deep gray matter atrophy detection over 5 years with 3T MRI in multiple sclerosis using a variety of automated segmentation pipelines.
Chu R; Kim G; Tauhid S; Khalid F; Healy BC; Bakshi R
PLoS One; 2018; 13(11):e0206939. PubMed ID: 30408094
[TBL] [Abstract][Full Text] [Related]
7. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
[TBL] [Abstract][Full Text] [Related]
8. An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Bakshi R; Neema M; Tauhid S; Healy BC; Glanz BI; Kim G; Miller J; Berkowitz JL; Bove R; Houtchens MK; Severson C; Stankiewicz JM; Stazzone L; Chitnis T; Guttmann CR; Weiner HL; Ceccarelli A
Neuroreport; 2014 Oct; 25(14):1156-61. PubMed ID: 25100554
[TBL] [Abstract][Full Text] [Related]
9. Dual-Sensitivity Multiple Sclerosis Lesion and CSF Segmentation for Multichannel 3T Brain MRI.
Meier DS; Guttmann CRG; Tummala S; Moscufo N; Cavallari M; Tauhid S; Bakshi R; Weiner HL
J Neuroimaging; 2018 Jan; 28(1):36-47. PubMed ID: 29235194
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
11. Inversion Recovery Ultrashort TE MR Imaging of Myelin is Significantly Correlated with Disability in Patients with Multiple Sclerosis.
Jang H; Ma YJ; Chang EY; Fazeli S; Lee RR; Lombardi AF; Bydder GM; Corey-Bloom J; Du J
AJNR Am J Neuroradiol; 2021 May; 42(5):868-874. PubMed ID: 33602747
[TBL] [Abstract][Full Text] [Related]
12. Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks.
Popescu V; Ran NC; Barkhof F; Chard DT; Wheeler-Kingshott CA; Vrenken H
Neuroimage Clin; 2014; 4():366-73. PubMed ID: 24567908
[TBL] [Abstract][Full Text] [Related]
13. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
Megna R; Alfano B; Lanzillo R; Costabile T; Comerci M; Vacca G; Carotenuto A; Moccia M; Servillo G; Prinster A; Brescia Morra V; Quarantelli M
J Neurol; 2019 Feb; 266(2):361-368. PubMed ID: 30498912
[TBL] [Abstract][Full Text] [Related]
14. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
[TBL] [Abstract][Full Text] [Related]
15. Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
Motl RW; Cadavid D; Sandroff BM; Pilutti LA; Pula JH; Benedict RH
J Neurol Sci; 2013 Dec; 335(1-2):169-73. PubMed ID: 24104065
[TBL] [Abstract][Full Text] [Related]
16. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction.
Sanfilipo MP; Benedict RH; Sharma J; Weinstock-Guttman B; Bakshi R
Neuroimage; 2005 Jul; 26(4):1068-77. PubMed ID: 15961046
[TBL] [Abstract][Full Text] [Related]
17. Monitoring disease activity and progression in primary progressive multiple sclerosis using MRI: sub-voxel registration to identify lesion changes and to detect cerebral atrophy.
Stevenson VL; Smith SM; Matthews PM; Miller DH; Thompson AJ
J Neurol; 2002 Feb; 249(2):171-7. PubMed ID: 11985382
[TBL] [Abstract][Full Text] [Related]
18. Single MRI-Based Volumetric Assessment in Clinical Practice Is Associated With MS-Related Disability.
D'hooghe MB; Gielen J; Van Remoortel A; D'haeseleer M; Peeters E; Cambron M; De Keyser J; Nagels G
J Magn Reson Imaging; 2019 May; 49(5):1312-1321. PubMed ID: 30597656
[TBL] [Abstract][Full Text] [Related]
19. Corpus callosum atrophy correlates with gray matter atrophy in patients with multiple sclerosis.
Klawiter EC; Ceccarelli A; Arora A; Jackson J; Bakshi S; Kim G; Miller J; Tauhid S; von Gizycki C; Bakshi R; Neema M
J Neuroimaging; 2015; 25(1):62-7. PubMed ID: 24816394
[TBL] [Abstract][Full Text] [Related]
20. Quantitative signal properties from standardized MRIs correlate with multiple sclerosis disability.
Brier MR; Snyder AZ; Tanenbaum A; Rudick RA; Fisher E; Jones S; Shimony JS; Cross AH; Benzinger TLS; Naismith RT
Ann Clin Transl Neurol; 2021 May; 8(5):1096-1109. PubMed ID: 33943045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]